219 related articles for article (PubMed ID: 35205694)
1. Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges.
Rafii S; Tashkandi E; Bukhari N; Al-Shamsi HO
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205694
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.
Yi L; Li J
Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687
[TBL] [Abstract][Full Text] [Related]
3. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges.
Martinez-Lage M; Puig-Serra P; Menendez P; Torres-Ruiz R; Rodriguez-Perales S
Biomedicines; 2018 Nov; 6(4):. PubMed ID: 30424477
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
6. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9: a new and promising player in gene therapy.
Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
9. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9: Transcending the Reality of Genome Editing.
Chira S; Gulei D; Hajitou A; Zimta AA; Cordelier P; Berindan-Neagoe I
Mol Ther Nucleic Acids; 2017 Jun; 7():211-222. PubMed ID: 28624197
[TBL] [Abstract][Full Text] [Related]
12. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
Ren J; Zhao Y
Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148
[TBL] [Abstract][Full Text] [Related]
13. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
14. Applications of the CRISPR-Cas9 system in kidney research.
Higashijima Y; Hirano S; Nangaku M; Nureki O
Kidney Int; 2017 Aug; 92(2):324-335. PubMed ID: 28433382
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 genome editing for cancer immunotherapy: opportunities and challenges.
Chen M; Xu J; Zhou Y; Zhang S; Zhu D
Brief Funct Genomics; 2020 May; 19(3):183-190. PubMed ID: 31788683
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles.
Dai WJ; Zhu LY; Yan ZY; Xu Y; Wang QL; Lu XJ
Mol Ther Nucleic Acids; 2016; 5(8):e349. PubMed ID: 28131272
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 and cancer targets: future possibilities and present challenges.
White MK; Khalili K
Oncotarget; 2016 Mar; 7(11):12305-17. PubMed ID: 26840090
[TBL] [Abstract][Full Text] [Related]
19. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More.
Ou X; Ma Q; Yin W; Ma X; He Z
Front Cell Dev Biol; 2021; 9():674467. PubMed ID: 34095145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
